|  Help  |  About  |  Contact Us

Publication : Co-opted integrin signaling in ErbB2-induced mammary tumor progression.

First Author  Carraway KL 3rd Year  2006
Journal  Cancer Cell Volume  10
Issue  2 Pages  93-5
PubMed ID  16904607 Mgi Jnum  J:112688
Mgi Id  MGI:3663194 Doi  10.1016/j.ccr.2006.07.015
Citation  Carraway KL 3rd, et al. (2006) Co-opted integrin signaling in ErbB2-induced mammary tumor progression. Cancer Cell 10(2):93-5
abstractText  Although almost two decades of study point to a central role for aberrant ErbB2 activation in breast cancer, many cellular and biochemical mechanisms underlying ErbB2-induced tumor initiation and progression remain to be resolved. A study by Guo et al. published recently in Cell indicates that the signaling function of beta4 integrin actively contributes to the initiation, growth, and invasion of ErbB2-induced mammary tumors in transgenic mice by promoting the activation of c-Jun and STAT3. These observations offer novel mechanistic insight into ErbB2 action and highlight the notion that ErbB2 co-opts the functions of other signaling proteins to elicit tumor progression.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

5 Bio Entities

Trail: Publication

0 Expression